Cargando…
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36
BACKGROUND: Up to now a malaria vaccine remains elusive. The Plasmodium falciparum serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage malaria vaccine candidate that has undergone phase 1a trial in malaria-naive Japanese adults. We have now assessed the safety an...
Autores principales: | Palacpac, Nirianne Marie Q., Ntege, Edward, Yeka, Adoke, Balikagala, Betty, Suzuki, Nahoko, Shirai, Hiroki, Yagi, Masanori, Ito, Kazuya, Fukushima, Wakaba, Hirota, Yoshio, Nsereko, Christopher, Okada, Takuya, Kanoi, Bernard N., Tetsutani, Kohhei, Arisue, Nobuko, Itagaki, Sawako, Tougan, Takahiro, Ishii, Ken J., Ueda, Shigeharu, Egwang, Thomas G., Horii, Toshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665850/ https://www.ncbi.nlm.nih.gov/pubmed/23724021 http://dx.doi.org/10.1371/journal.pone.0064073 |
Ejemplares similares
-
The development of the BK-SE36 malaria vaccine candidate
por: Palacpac, Nirianne MQ, et al.
Publicado: (2014) -
Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda
por: Yagi, Masanori, et al.
Publicado: (2016) -
Hematological and Biochemical Data Obtained in Rural Northern Uganda
por: Palacpac, Nirianne M. Q., et al.
Publicado: (2014) -
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination
por: Arisue, Nobuko, et al.
Publicado: (2022) -
Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population
por: Kanoi, Bernard N., et al.
Publicado: (2020)